Skip to main content
Discover what's not being covered
Get Started
SubscribeLogin
Published • loading... • Updated

Randomized phase III trial with a factorial design assessing the efficacy

Summary by BIOENGINEER.ORG
The PEACE 7 protocol plans a 700-patient phase III trial testing darolutamide and a prostate stereotactic radiotherapy boost in men with high-risk localized prostate cancer.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

BIOENGINEER.ORGBIOENGINEER.ORG

Randomized phase III trial with a factorial design assessing the efficacy

The PEACE 7 protocol plans a 700-patient phase III trial testing darolutamide and a prostate stereotactic radiotherapy boost in men with high-risk localized prostate cancer.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

BIOENGINEER.ORG broke the news on Tuesday, October 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Peace icon

Peace

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal